Intrinsic Value of S&P & Nasdaq Contact Us

Denali Therapeutics Inc. DNLI NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
62/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$34.40
+70.6%

Denali Therapeutics Inc. (DNLI) has 20 known insider and institutional holders on record. The largest holder is BIOGEN INC. with 13,310,243 shares. Other notable holders include ARCH Venture Fund VIII, L.P. and BRATTON DOUGLAS K.

Over the last 12 months, insiders have made 23 transactions in DNLI stock — 12 buys (valued at $8.38M) and 5 sells (valued at $956.43K). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

DNLI Insider Ownership

Top Holder
BIOGEN INC.
13,310,243 shares
Buys (12 mo)
12
$8.38M value
Sells (12 mo)
5
$956.43K value
12-Month Transaction Activity
Buy 52%
Sell 22%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Biogen Inc. 10 Percent Owner 13,310,243 2020-09-28
100%
2 Arch Venture Fund Viii, L.p. 10 Percent Owner 10,668,749 2019-08-12
80%
3 Bratton Douglas K 10 Percent Owner 9,984,836 2021-02-17
75%
4 Baker Bros. Advisors Lp Director 2,335,469 2025-12-15
18%
5 Watts Ryan J. President and CEO 296,833 2026-01-08
2%
6 Schuth Alexander O. Cofo and Secretary 282,828 2026-01-08
2%
7 Ho Carole Chief Medical Officer 217,391 2025-08-14
2%
8 Sato Vicki L Director 107,976 2025-01-03
1%
9 Fmr Llc 10 Percent Owner 33,215 2017-12-22
0%
10 Cook Jennifer E. Director 18,111 2025-06-05
0%
11 Klein Peter S Director 18,111 2025-06-05
0%
12 Thornberry Nancy Director 18,111 2025-06-05
0%
13 Krognes Steve E. Director 18,111 2025-06-05
0%
14 Tessier-lavigne Marc Director 18,111 2025-06-05
0%
15 Harris Erik Director 17,052 2024-06-04
0%
16 Flatley Jay T Director 16,220 2025-06-05
0%
17 Schenkein David P Director 15,257 2025-06-05
0%
18 Cole Douglas G. Director 12,649 2023-06-05
0%
19 Van Hauwermeiren Timothy Director 10,632 2025-11-06
0%
20 Nelsen Robert Director 6,222 2021-06-04
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-01-06 Schuth Alexander O. Cofo and Secretary Informative Sell 17,218 $16.50 $284.1K
2026-01-06 Watts Ryan J. President and CEO Informative Sell 35,198 $16.50 $580.77K
2026-01-03 Schuth Alexander O. Cofo and Secretary RSU Award 173,100 $16.27 $2.82M
2026-01-03 Watts Ryan J. President and CEO RSU Award 236,880 $16.27 $3.85M
2025-12-11 Baker Bros. Advisors Lp Director Informative Buy 190,523 $0.01 $1.91K
2025-11-04 Van Hauwermeiren Timothy Director RSU Award 10,632 - -
2025-11-04 Van Hauwermeiren Timothy Director Unknown - - -
2025-09-03 Watts Ryan J. President and CEO Gift (Given) 50,000 - -
2025-08-13 Ho Carole Chief Medical Officer Informative Sell 806 $14.64 $11.8K
2025-08-12 Ho Carole Chief Medical Officer Informative Sell 2,937 $13.58 $39.88K
2025-08-12 Schuth Alexander O. Cofo and Secretary Informative Sell 2,937 $13.58 $39.88K
2025-08-05 Ho Carole Chief Medical Officer Option Exercise (Sell) 44,655 $0.68 $30.37K
2025-07-09 Watts Ryan J. President and CEO Option Exercise (Sell) 40,000 $5.28 $211.2K
2025-06-03 Thornberry Nancy Director RSU Award 18,111 $13.93 $252.29K
2025-06-03 Cook Jennifer E. Director RSU Award 18,111 $13.93 $252.29K
2025-06-03 Krognes Steve E. Director RSU Award 18,111 $13.93 $252.29K
2025-06-03 Schenkein David P Director RSU Award 6,037 - -
2025-06-03 Klein Peter S Director RSU Award 18,111 $13.93 $252.29K
2025-06-03 Tessier-lavigne Marc Director RSU Award 18,111 $13.93 $252.29K
2025-06-03 Baker Bros. Advisors Lp Director RSU Award 31,695 $13.93 $441.51K
2025-06-03 Baker Bros. Advisors Lp Director Unknown 23,901,119 $0.01 $239.01K
2025-06-03 Flatley Jay T Director RSU Award 6,037 - -
2025-06-03 Baker Julian Officer Unknown - - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message